Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary: objective The dynamics of the plasma concentrations of various diagnostic determinants of thyroid function were analysed in children with congenital hypothyroidism (CH) after the start of T4 supplementation. The description of the biochemical dynamics of TSH and free T4 (FT4) during the first period of thyroxine treatment is important to depict the practical outlines of the initial dosage of T4 and dosage adjustments for newborns with variable forms of CH. design A retrospective analysis was performed of frequent plasma TSH, total T4 (T4), FT4 and total T3 (T3) measurements in 30 CH neonates during the first weeks of treatment, treated with initial daily T4 dosages ranging from 4·8 to 11·1 µg/kg. results A 50% reduction in the initial plasma TSH concentration was achieved after 3–4 days of treatment, independent of CH severity. At a median of 32 days after the start of T4 supplementation, plasma TSH ranged between 0·4 and 4·0 mU/l. The mean interval needed for FT4 to reach the age‐related normal values (12–29 pmol/l) was 3 days. The increase in plasma T3 concentrations levelled off within a few days, when T4 reached concentrations of around 100 nmol/l. conclusions Plasma T3 and FT4 concentrations reach the normal range a few days after thyroxine treatment is started. By contrast, normalization of plasma TSH concentration takes several weeks. At the time that plasma TSH is normalized, CH neonates show a higher range of plasma FT4 concentrations than the normal range. When TSH normalization is the goal of treatment in CH, the target range for plasma FT4 during treatment in the first months needs to be adapted. During the first month of treatment the plasma TSH concentration is not helpful in assessing the proper T4 supplementation dosage. Once plasma TSH has reached normal values, it becomes a reliable determinant in addition to plasma FT4.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vulsma, T., Gons, M. H., & de Vijlder, J. J. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907063210103 · Cited by 795
Self-citationEscobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287
Escobar-Morreale, H. F., del Rey, F. E., Obregón, M. J., & de Escobar, G. M. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641203 · Cited by 261
Kooistra, L., Laane, C., Vulsma, T., Schellekens, J. M. H., van der Meere, J. J., & Kalverboer, A. F. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83178-6 · Cited by 185
Self-citationRelationship of Etiology to Treatment in Congenital Hypothyroidism
Hanukoglu, A., Perlman, K., Shamis, I., Brnjac, L., Rovet, J., & Daneman, D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7124 · Cited by 93
Outcome for congenital hypothyroidism.
Hulse, J. A. (1984) · Archives of Disease in Childhood · doi:10.1136/adc.59.1.23 · Cited by 75
Cited by
Update of Newborn Screening and Therapy for Congenital Hypothyroidism
American Academy of Pediatrics, Rose, S. R., and the Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown, R. S., and the Public Health Committee, & Lawson Wilkins Pediatric Endocrine Society (2006) · Pediatrics · doi:10.1542/peds.2006-0915 · Cited by 798
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“Consequently, fT4 (or total T4) should guide dosing until TSH reaches the agespecific reference interval (99).”
BackgroundKempers, M. J. E., van der Sluijs Veer, L., Nijhuis-van der Sanden, M. W. G., Kooistra, L., Wiedijk, B. M., Faber, I., Last, B. F., de Vijlder, J. J. M., Grootenhuis, M. A., & Vulsma, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1209 · Cited by 122
Self-citationSimoneau-Roy, J., Marti, S., Deal, C., Huot, C., Robaey, P., & Van Vliet, G. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.02.021 · Cited by 123
Kempers, M. J. E., van der Sluijs Veer, L., Nijhuis-van der Sanden, R. W. G., Lanting, C. I., Kooistra, L., Wiedijk, B. M., Last, B. F., de Vijlder, J. J. M., Grootenhuis, M. A., & Vulsma, T. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1538 · Cited by 85
“However, in a previous study we could not demonstrate a solid correlation between the height of the initial T4 dose and the time needed to reach a plasma FT4 concentration within the reference range (19).”
BackgroundSelf-citation
Metadata
- Authors
- Bakker, B., Kempers, M. J. E., De Vijlder, J. J. M., Van Tijn, D. A., Wiedijk, B. M., Van Bruggen, M., & Vulsma, T.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2002-09-27
- Volume
- 57
- Issue
- 4
- Pages
- 529-537
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2103918459
- Cited by
- 48
- References
- 6
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism. https://app.cochat.ai/papers/10.1046/j.1365-2265.2002.01632.x
- The paper
- Bakker, B., Kempers, M. J. E., De Vijlder, J. J. M., Van Tijn, D. A., Wiedijk, B. M., Van Bruggen, M., & Vulsma, T. (2002). Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2002.01632.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.